# CVS HEALTH CORPORATION (CVS) FY2024 Q3 Balance Sheet

- Company: CVS HEALTH CORPORATION (CVS)
- Period: As of 2024-09-30
- Filing: Q3 FY2024 10-Q, filed 2024-11-06, accession number 0000064803-24-000034
- Page: https://plicit.ai/financials/cvs/fy2024-q3-balance-sheet
- Chart image: https://plicit.ai/charts/cvs-fy2024-q3-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2024-09-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 252,427,000,000 US dollars
- **Current assets**: 67,343,000,000 US dollars
- **Non-current assets**: 185,084,000,000 US dollars
- **Liabilities**: 177,321,000,000 US dollars
- **Current liabilities**: 84,627,000,000 US dollars
- **Non-current liabilities**: 92,694,000,000 US dollars
- **Equity**: 75,106,000,000 US dollars
- **Noncontrolling interest**: 162,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Accounts receivable, net**: 36,179,000,000 US dollars
- **Inventories**: 17,649,000,000 US dollars
- **Cash and cash equivalents**: 6,875,000,000 US dollars
- **Other current assets**: 3,835,000,000 US dollars
- **Investments**: 2,805,000,000 US dollars
- **Goodwill**: 91,272,000,000 US dollars
- **Long-term investments**: 28,939,000,000 US dollars
- **Intangible assets, net**: 27,817,000,000 US dollars
- **Operating lease right-of-use assets**: 16,231,000,000 US dollars
- **Property and equipment, net**: 12,728,000,000 US dollars
- **Other assets**: 4,763,000,000 US dollars
- **Separate accounts assets**: 3,334,000,000 US dollars
- **Pharmacy claims and discounts payable**: 23,917,000,000 US dollars
- **Accrued expenses**: 20,174,000,000 US dollars
- **Accounts payable**: 15,713,000,000 US dollars
- **Health care costs payable**: 15,237,000,000 US dollars
- **Current portion of long-term debt**: 4,910,000,000 US dollars
- **Current portion of operating lease liabilities**: 1,912,000,000 US dollars
- **Other insurance liabilities**: 1,051,000,000 US dollars
- **Policyholders’ funds**: 913,000,000 US dollars
- **Short-term debt**: 800,000,000 US dollars
- **Long-term debt**: 59,824,000,000 US dollars
- **Long-term operating lease liabilities**: 15,258,000,000 US dollars
- **Other long-term liabilities**: 5,484,000,000 US dollars
- **Other long-term insurance liabilities**: 5,162,000,000 US dollars
- **Deferred income taxes**: 3,632,000,000 US dollars
- **Separate accounts liabilities**: 3,334,000,000 US dollars
- **Retained earnings**: 62,038,000,000 US dollars
- **Common stock, par value $0.01: 3,200 shares authorized; 1,777 shares issued and 1,258 shares outstanding at September 30, 2024 and 1,768 shares issued and 1,288 shares outstanding at December 31, 2023 and capital surplus**: 49,510,000,000 US dollars
- **Accumulated other comprehensive income (loss)**: 209,000,000 US dollars
- **Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding**: 0 US dollars
- **Noncontrolling interests**: 162,000,000 US dollars
- **Treasury stock, at cost: 519 shares at September 30, 2024 and 480 shares at December 31, 2023**: negative 36,813,000,000 US dollars
- **Gross equity (calculated)**: 111,919,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.